Are European laboratories ready to detect COVID-19?
A first assessment looking at the preparedness of EU/EEA laboratories to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates a fast implementation of molecular diagnostics by the European specialised laboratory networks. It also shows a good geographical coverage for testing.
In January 2020, a survey among laboratories to assess the capacity and quality for SARS-CoV-2 (previously 2019-nCoV) diagnostics as well as implementation barriers was conducted. The data provided by 47 laboratories in 30 EU/EEA countries were taken into account in a study released by Eurosurveillance.
The laboratories were asked to indicate their weekly capacity for molecular testing for SARS-CoV-2. Of the 47 participating laboratories, 38 indicated a capacity of minimum 8 275 tests per week.
At the time of the survey, an additional eight laboratories were in the process of implementing molecular diagnostics and these laboratories would, all combined, add a minimum capacity of 875 tests per week once this process would be complete.
Furthermore, the survey indicated a great willingness of laboratories to provide international diagnostic support and to share sequences to contribute to the monitoring of virus evolution and trace transmission chains.
The main challenges for test implementation were an initial lack of positive control, lack of personnel/time and a lack of primers and/or probes.
Read the full assessment
A first assessment looking at the preparedness of EU/EEA laboratories to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates a fast implementation of molecular diagnostics by the European specialised laboratory networks. It also shows a good geographical coverage for testing.
Latest updates
Further reading
This issue of the Communicable disease threats report (CDTR) covers the period 10 - 16 October 2026, and includes updates on respiratory virus epidemiology in the EU/EEA, Ebola, expert deployment, pneumonia of unknown aetiology, mpox in the EU/EEA, West Nile Virus, Crimean-Congo haemorrhagic fever, dengue, chikungunya, and diphtheria.
Communicable disease threats report, 10 - 16 October, week 42
English (2.67 MB - PDF)
This issue of the Communicable disease threats report (CDTR) covers the period 3 - 9October 2026, and includes updates on respiratory virus epidemiology in the EU/EEA, pneumonia of unknown aetiology, Ebola, expert deployment, West Nile Virus, Crimean-Congo haemorrhagic fever, dengue, chikungunya, symptomatic Sindbis case in Germany, measles, and Salmonella Strathcona.
Communicable disease threats report, 3 - 9 October, week 41
English (2.64 MB - PDF)
This issue of the Communicable disease threats report (CDTR) covers the period 26 September - 2 October 2026, and includes updates on Crimean Congo haemorrhagic fever, Chikungunya virus disease, cholera, COVID-19, dengue, Ebola, avian influenza, seasonal influenza, Middle Eastern Respiratory Syndrome (MERS), respiratory syncytial infection, Vibriosis and West Nile virus infection.
Communicable disease threats report, 26 September - 2 October, week 40
English (8.98 MB - PDF)
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 September, and includes updates on respiratory virus epidemiology in the EU/EEA Ebola, ECDC expert deployment, West Nile Virus, Crimean-Congo haemorrhagic fever, dengue, chikungunya, and vibrio risk in coastal waters.
Communicable disease threats report, 19-25 September, week 39
English (2.91 MB - PDF)
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 September, and includes updates on Ebola, malaria, botulism, avian influenza A(H9N2), influenza A(H5), respiratory virus epidemiology in the EU/.EEA, West Nile virus infections, chikungunya, dengue, Crimean-Congo haemorrhagic fever, Vibrio, measles, and expert deployments.
Communicable disease threats report, 12-18 September, week 38
English (3.41 MB - PDF)